We are live on
!
Find out more
Royal London Asset Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.49%
1 Year Est. Return
+29.41%
3 Year Est. Return
+102.29%
5 Year Est. Return
+137.02%
10 Year Est. Return
–
AUM
$26.9B
AUM Growth
+$2.26B
(+9.2%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
31.19%
Holding
676
New
12
Increased
130
Reduced
391
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$148M |
| 2 |
Mercado Libre
MELI
|
+$64.3M |
| 3 |
Progressive
PGR
|
+$31.6M |
| 4 |
Autodesk
ADSK
|
+$29.1M |
| 5 |
Brookfield
BN
|
+$24.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$82.2M |
| 2 |
Apple
AAPL
|
+$61.7M |
| 3 |
Salesforce
CRM
|
+$58.7M |
| 4 |
Micron Technology
MU
|
+$41.5M |
| 5 |
ExxonMobil
XOM
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.82% |
| 2 | Healthcare | 14.43% |
| 3 | Financials | 11.51% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Idexx Laboratories
IDXX
$45.1B
| $50.3M | 0.19% |
76,367
-9,152
| -11% | -$5.75M |
|
102
US Bancorp
USB
$101B
| $49.8M | 0.19% |
887,541
-72,777
| -8% | -$4.3M |
|
103
Medtronic
MDT
$114B
| $49.2M | 0.18% |
476,042
-2,635
| -0.6% | -$305K |
|
104
Ametek
AME
$59.1B
| $49.2M | 0.18% |
334,266
-26,782
| -7% | -$3.66M |
|
105
Bristol-Myers Squibb
BMY
$131B
| $48.3M | 0.18% |
774,890
-21,604
| -3% | -$1.27M |
|
106
Ford
F
$55.3B
| $48.1M | 0.18% |
2,316,534
-128,440
| -5% | -$2.36M |
|
107
CVS Health
CVS
$120B
| $46.6M | 0.17% |
452,046
-19,098
| -4% | -$1.76M |
|
108
Starbucks
SBUX
$121B
| $46.4M | 0.17% |
396,992
-17,186
| -4% | -$1.94M |
|
109
Morgan Stanley
MS
$346B
| $46.4M | 0.17% |
472,871
-17,563
| -4% | -$1.75M |
|
110
Gilead Sciences
GILD
$169B
| $45.8M | 0.17% |
630,306
-27,025
| -4% | -$1.86M |
|
111
PACCAR
PCAR
$68.5B
| $45.6M | 0.17% |
774,518
+29,459
| +4% | +$1.7M |
|
112
RTX Corp
RTX
$297B
| $45.5M | 0.17% |
529,307
-2,379
| -0.4% | -$207K |
|
113
Mettler-Toledo International
MTD
$28.5B
| $44.9M | 0.17% |
26,471
-2,420
| -8% | -$3.66M |
|
114
Snowflake
SNOW
$117B
| $44.3M | 0.16% |
130,733
-55,412
| -30% | -$19.3M |
|
115
Amgen
AMGN
$225B
| $43.9M | 0.16% |
195,066
-9,694
| -5% | -$2.05M |
|
116
ServiceNow
NOW
$127B
| $43.7M | 0.16% |
336,160
-8,270
| -2% | -$1.09M |
|
117
General Motors
GM
$76.5B
| $43.6M | 0.16% |
743,975
+514
| +0.1% | +$30K |
|
118
Moderna
MRNA
$24.7B
| $43.3M | 0.16% |
170,336
+50,701
| +42% | +$14.8M |
|
|
SCHW
119
Charles Schwab
SCHW
$187B
| $42.9M | 0.16% |
510,168
-10,234
| -2% | -$828K |
|
120
IBM
IBM
$220B
| $42.7M | 0.16% |
319,261
-17,011
| -5% | -$2.13M |
|
121
Citigroup
C
$232B
| $42.4M | 0.16% |
701,910
-29,150
| -4% | -$1.94M |
|
122
Colgate-Palmolive
CL
$73.7B
| $42.3M | 0.16% |
496,269
-18,462
| -4% | -$1.44M |
|
123
Zoetis
ZTS
$29.9B
| $41.6M | 0.15% |
170,624
| – | – |
|
124
Exelon
EXC
$46.3B
| $41.2M | 0.15% |
998,509
| – | – |
|
125
CDW
CDW
$16.8B
| $40.8M | 0.15% |
199,382
-36,395
| -15% | -$6.92M |
|
Similar funds
TI
RIM
LP
Royal London Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Royal London Asset Management held 676 positions worth $26.9B, up 9.2% from $24.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Royal London Asset Management withdrew a net $1.14B in Q4 2021, closing 17 positions and reducing 391 holdings. Its most notable exit was Globant, an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Royal London Asset Management opened a new position in Brookfield worth $25.6M.
- Royal London Asset Management's largest Q4 2021 buy was Brookfield: 786,970 shares worth $25.6M.
- Royal London Asset Management added most to NVIDIA in Q4 2021, an estimated $148M increase.
- Royal London Asset Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $82.2M.
- Royal London Asset Management fully exited Globant in Q4 2021, selling an estimated $14M.
- Royal London Asset Management's ten largest holdings make up 31% of its $26.9B portfolio in Q4 2021.
- Royal London Asset Management opened 12 new positions and closed 17 in Q4 2021.
- Royal London Asset Management's portfolio value rose 9.2% quarter-over-quarter to $26.9B.
Based on Royal London Asset Management's 13F filing for Q4 2021, filed 18 Jan 2022.